Ahmad S, Yang W, Orellana A, Frölich L, de Rojas I, Cano A, Boada M, Hernández I, Hausner L, Harms AC, Bakker MHM, Cabrera-Socorro A, Amin N, Ramirez A, Ruiz A, van Duijn CM, Hankemeier T. Association of oxidative stress and inflammatory metabolites with Alzheimer's disease cerebrospinal fluid biomarkers in mild cognitive impairment. Alzheimers Res Ther. 2024 16(1):171.
Cesana BM, Bergh S, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Frölich L, Handels R, Jori MC, Mecocci P, Merlo P, Peters O, Tsolaki M, Defanti CA. Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study. J Alzheimers Dis. 2024 98:1043-1052. Epub 2024 Mar 12.
Couturier SP, Spielmann-Benson G, Frölich L, Hausner L. [Inpatient Equivalent Home Treatment of Gerontopsychiatric Patients (ieht-g) in a Major German City - An Observational Study]. Psychiatr Prax. 2024 51(7):385-391. Epub 2024 Jul 22.
Dafsari FS, Bewernick B, Böhringer S, Domschke K, Elsaesser M, Löbner M, Luppa M, Schmitt S, Wingenfeld K, Wolf E, Zehender N, Hellmich M, Müller W, Wagner M, Peters O, Frölich L, Riedel-Heller S, Schramm E, Hautzinger M, Jessen F. Perceived Physical Health and Cognitive Behavioral Therapy vs Supportive Psychotherapy Outcomes in Adults With Late-Life Depression: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 7(4):e245841.
Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D, Kivipelto M, Jessen F, Hanseeuw B, Boada M, Barkhof F, Nordberg A, Froelich L, Waldemar G, Frederiksen KS, Padovani A, Planche V, Rowe C, Bejanin A, Ibanez A, Cappa S, Caramelli P, Nitrini R, Allegri R, Slachevsky A, de Souza LC, Bozoki A, Widera E, Blennow K, Ritchie C, Agronin M, Lopera F, Delano-Wood L, Bombois S, Levy R, Thambisetty M, Georges J, Jones DT, Lavretsky H, Schott J, Gatchel J, Swantek S, Newhouse P, Feldman HH, Frisoni GB. Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation. JAMA Neurol. 2024 81(12):1304-1311. Epub 2024 Nov 1.
Jessen F, Frölich L, Hort J, Winblad B, Fortea J. Amyloid-lowering treatment in Alzheimer's disease. Lancet. 2024 404(10468):2161-2162. Epub 2024 Nov 14.
Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, Boada M, Boban M, Chincarini A, Exalto L, Felbecker A, Fliessbach K, Frisoni GB, Garza-Martínez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Klöppel S, Krajcovicova L, McGuinness B, Mecocci P, de Mendonça A, Nous A, Ousset PJ, Paquet C, Perneczky R, Peters O, Tabuas-Pereira M, Piazza F, Plantone D, Riverol M, Ruiz A, Sacco G, Santana I, Scarmeas N, Solje E, Stefanova E, Sutovsky S, van der Flier W, Welsh T, Wimo A, Winblad B, Frölich L, Engelborghs S. Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators. J Prev Alzheimers Dis. 2024 11(5):1212-1218.
Kerl HU, Baazaoui H, Herrmann K, Adlung A, Ludwig NK, Hausner L, Frölich L, Schad L, Groden C, Mohamed SA. Sodium signal intensity of CSF using 1H-guided 23Na-MRI as a potential noninvasive biomarker in Alzheimer's disease. J Neuroimaging. 2024 34(5):619-626. Epub 2024 May 28.
Koetsier J, Cavill R, Reijnders R, Harvey J, Homann J, Kouhsar M, Deckers K, Köhler S, Eijssen LMT, van den Hove DLA, Demuth I, Düzel S, Alzheimer's Disease Neuroimaging Initiative , Smith RG, Smith AR, Burrage J, Walker EM, Shireby G, Hannon E, Dempster E, Frayling T, Mill J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund-Levi Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, De Roeck E, Martinez-Lage P, Tainta M, Lleo A, Sala I, Popp J, Peyratout G, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJ, Lovestone S, Visser PJ, Lill CM, Bertram L, Lunnon K, Pishva E. Blood-based multivariate methylation risk score for cognitive impairment and dementia. Alzheimers Dement. 2024 20(10):6682-6698. Epub 2024 Aug 28.
Löffler A, Beier F, Bekrater-Bodmann R, Hausner L, Desch S, Silvoni S, Kleinböhl D, Löffler M, Nees F, Frölich L, Flor H. Reduced tactile sensitivity is associated with mild cognitive impairment. EBioMedicine. 2024 99:104896. Epub 2023 Dec 1.
Mattke S, Tang Y, Hanson M, von Arnim CAF, Frölich L, Grimmer T, Onur OA, Perneczky R, Teipel S, Thyrian JR. Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times. J Alzheimers Dis. 2024 101(4):1249-1259. Epub 2024 Sep 17.
Müller J, Elsaesser M, Müller W, Hellmich M, Hammen M, Zehender N, Riedel-Heller S, Bewernick BH, Wagner M, Frölich L, Peters O, Dafsari FS, Domschke K, Jessen F, Hautzinger M, Schramm E. Differential Psychological Treatment Effects in Patients With Late-Life Depression and a History of Childhood Maltreatment. Am J Geriatr Psychiatry. 2024 32(11):1325-1336. Epub 2024 May 17.
Nielsen TR, de Mendonça A, Frölich L, Engelborghs S, Gove D, Lamirel D, Calia C, Waldemar G. Assessment of Dementia in Minority Ethnic Groups in Europe: A 14-Year Follow-Up Survey. Int J Geriatr Psychiatry. 2024 39(12):e70034.
Perneczky R, Hansen N, Hofmann A, Laske C, Priller J, Grimmer T, Frölich L, Düzel E, Jessen F, Wiltfang J, German Network Memory Clinics – Diagnostic Tools Working Group . Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World Settings. Methods Mol Biol. 2024 2785:3-14.
Schönberger AR, Steinmetz A, Schild AK, Hausner L, Spielmann-Benson G, Frölich L, Jessen F. Dementia Care Practice. Alzheimers Dement. 2024 20 Suppl 5(Suppl 5):e089190.
Smith RG, Pishva E, Kouhsar M, Imm J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund-Levi Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, De Roeck E, Martinez-Lage P, Altuna M, Tainta M, Lleo A, Sala I, Popp J, Peyratout G, Winchester L, Nevado-Holgado A, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJ, Lovestone S, Visser PJ, Bertram L, Lunnon K. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study. Alzheimers Dement. 2024 20(10):6722-6739. Epub 2024 Aug 28.